Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer

International Journal of Cancer

Volumn 128, Issue 9, 2011, Pages 2063-2074

  Notaridou, Maria ^a   Quaye, Lydia ^a   Dafou, Dimitra ^b   Jones, Chris ^a   Song, Honglin ^c   Høgdall, Estrid ^d   Kjaer, Susanne K ^d   Christensen, Lise ^e   Høgdall, Claus ^e   Blaakaer, Jan ^f   McGuire, Valerie ^g   Wu, Anna H ^h   Van Den Berg, David J ^h   Pike, Malcolm C ^h   Gentry Maharaj, Aleksandra ^a   Wozniak, Eva ^a   Sher, Tanya ^a   Jacobs, Ian J ^a   Tyrer, Jonathan ^c   Schildkraut, Joellen M ⁱ   Moorman, Patricia G ⁱ   Iversen, Edwin S ⁱ   Jakubowska, Anna ^j   Mȩdrek, Krzysztof ^j   Lubiński, Jan ^j   Ness, Roberta B ^k   Moysich, Kirsten B ^l   Wilkens, Lynne R ^m   Carney, Michael E ^m   Wang Gohrke, Shan ⁿ   Doherty, Jennifer A ^o   Rossing, Mary Anne ^o   Beckmann, Matthias W ^p   Thiel, Falk C ^p   Ekici, Arif B ^q   Chen, Xiaoqing ^r   Beesley, Jonathan ^r   Gronwald, Jacek ^j   Fasching, Peter A ^p,s   Chang Claude, Jenny ^t   Goodman, Marc T ^m   Chenevix Trench, Georgia ^r   Berchuck, Andrew ^u   Pearce, C Leigh ^h   Whittemore, Alice S ^g   Menon, Usha ^a   Pharoah, Paul D P ^c   Gayther, Simon A ^a   Ramus, Susan J ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j POMERANIAN MEDICAL UNIVERSITY   (Poland)

^k UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^l ROSWELL PARK CANCER INSTITUTE   (United States)

^m UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁿ UNIVERSITY OF ULM   (Germany)

^o Fred Hutchinson Cancer Research Center   (United States)

^p UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^q UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^r ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^u DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Association studies; Polymorphism; Risk of ovarian cancer

Indexed keywords

AIFM2 GENE; AKTIP GENE; ALLELE; ARTICLE; AUSTRALIA; AXIN2 GENE; CANCER CELL; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASP5 GENE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EUROPE; FILIP1L GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOSS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HETEROZYGOSITY LOSS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION GENETICS; PRIMARY TUMOR; PRIORITY JOURNAL; RBBP8 GENE; RGC32 GENE; RUVBL1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STAG3 GENE; TUMOR SUPPRESSOR GENE; UNITED STATES;

ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79952465565     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25554     Document Type: Article

References (42)

1. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder BA. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997; 336:1125-30.
2. Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, et al. Screening for the. BRCA1-ins6kb. Ex13 mutation: potential for misdiagnosis. Mutation in brief #964. Online. Hum Mutat 2007;28:525-6.
3. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 1999;65:1021-9. (Pubitemid 30462958)
4. Antoniou AC, Easton DF. Risk prediction models for familial breast cancer. Future Oncol 2006;2:257-74.
5. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-36.
6. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008;17:R109-15.
7. McCarthy MI, Hirschhorn JN. Genomewide association studies: past, present and future. Hum Mol Genet 2008;17: R100-1.
8. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 2005;97:51-9.
9. Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, et al. Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res 2006;66: 10220-6. (Pubitemid 44672078)
10. Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, et al. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS ONE 2007;2:e268.
11. Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 2006;27:2235-42. (Pubitemid 44644812)
12. Quaye L, Song H, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, et al. Tagging single nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer 2009;100:993-1001.
13. Fasching PA, Gayther SA, Pearce CL, Schildkraut JM, Goode E, Thiel F, Chenevix-Trench G, Chang-Claude J, Wang-Gohrke S, Ramus SJ, Pharoah PDP, Berchuck A, et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2009;3:171-81.
14. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007; 67:3027-35. (Pubitemid 46724839)
15. Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, et al. Consortium analysis of seven candidate snps for ovarian cancer. Int J Cancer 2008; 123:380-8.
16. Quaye L, Dafou D, Ramus SJ, Song H, Gentry-Maharaj A, Notaridou M, Hogdall E, Kjaer SK, Christensen L, Hogdall C, Easton DF, Jacobs I, et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 2009;18:1869-78.
17. Dafou D, Ramus SJ, Choi K, Grun B, Trott DA, Newbold RF, Jacobs IJ, Jones C, Gayther SA. Neoplastic suppression in epithelial ovarian cancer cells lines by microcell-mediated transfer of chromosomes 5, 6 and 18. Int J Cancer 2009;124:1037-44.
18. Provencher DM, Lounis H, Champoux L, Tétrault M, Manderson EN, Wang JC, Eydoux P, Savoie R, Tonin PN, Mes- Masson AM. Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell Dev Biol Anim 2000;36:357-61. (Pubitemid 30626747)
19. Benjamini Y, Yekutieli D. Quantitative trait loci analysis using the false discovery rate. Genetics 2005;171:783-90. (Pubitemid 43156463)
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
21. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.
22. Song H, Ramus SJ, Tyrer J, Bolton K, Gentry-Maharaj A, Wozniak E, Anton- Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, et al. Genome-wide association study identifies a novel ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009;41:996-1000.
23. Khalique L, Ayhan A, Weale M, Jacobs IJ, Ramus SJ, Gayther SA. Genetic intra tumour heterogeneity in epithelial ovarian cancer: the implications for clinical diagnostics. J Pathol 2007;211:286-95. (Pubitemid 46172704)
24. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996;56:3331-7. (Pubitemid 26242985)
25. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003;55:27-36. (Pubitemid 36928743)
26. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9. (Pubitemid 34680308)
27. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002;53:79-91. (Pubitemid 34621657)
28. Knudson AG. All in the (cancer) family. Nat Genet 1993;5:103-104. (Pubitemid 23293440)
29. Thomas DC, Haile RW, Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 2005;77:337-45. (Pubitemid 41192641)
30. Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 2004; 10:2473-81. (Pubitemid 38445709)
31. Pearce CL, Wu AH, Gayther SA, Bale AE; Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer 2008;98:282-8. (Pubitemid 351161257)
32. LaFramboise T, Weir BA, Zhao X, Beroukhim R, Li C, Harrington D, Sellers WR, Meyerson M. Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 1:e65, 2005.
33. Mao X, Hamoudi RA, Talbot IC, Baudis M. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II. Cancer Genet Cytogenet 2006;167:1-14.
34. Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Genes Chromosomes Cancer 2004;40:190-203. (Pubitemid 38703096)
35. Wang M, Vikis HG, Wang Y, Jia D, Wang D, Bierut LJ, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, et al. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res 2007;67:93-9. (Pubitemid 46142763)
36. Wegman PP, Marcus NJ, Malakkaran BP, Wingren S. Biological significance of allele specific loss of the p53 gene in breast carcinomas. Breast Cancer Res Treat 2009; 118:15-20.
37. Pezzi N, Prieto I, Kremer L, Pérez Jurado LA, Valero C, Del Mazo J, Martínez-A C, Barbero JL. STAG3, a novel gene encoding a protein involved in meiotic chromosome pairing and location of STAG3-related genes flanking the Williams-Beuren syndrome deletion. FASEB J 2000;14: 581-92. (Pubitemid 30143178)
38. Prieto I, Suja JA, Pezzi N, Kremer L, Martínez-A C, Rufas JS, Barbero JL. Mammalian STAG3 is a cohesin specific to sister chromatid arms in meiosis I. Nat Cell Biol 2001;3: 761-6. (Pubitemid 32734256)
39. Novak I, Lightfoot DA, Wang H, Eriksson A, Mahdy E, Höög C. Mouse embryonic stem cells form follicle-like ovarian structures but do not progress through meiosis. Stem Cells 2006;24:1931-6. (Pubitemid 44474169)
40. Kalejs M, Ivanov A, Plakhins G, Cragg MS, Emzinsh D, Illidge TM, Erenpreisa J. Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe. BMC Cancer 2006;6:6.
41. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, Barrett I, Nouhi Y, Spencer F, Markowitz S, Velculescu VE, Kinzler KW, et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci USA 2008;105:3443-8. (Pubitemid 351723572)
42. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005;65:5588-98. (Pubitemid 40911159)